Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 327,850
  • Shares Outstanding, K 70,810
  • Annual Sales, $ 61,990 K
  • Annual Income, $ 5,290 K
  • 36-Month Beta 0.53
  • Price/Sales 5.51
  • Price/Cash Flow N/A
  • Price/Book 7.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.10
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.12
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +65.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.02 +15.17%
on 01/24/19
4.75 -2.53%
on 02/15/19
+0.48 (+11.57%)
since 01/15/19
3-Month
2.80 +65.36%
on 12/24/18
4.75 -2.53%
on 02/15/19
+0.87 (+23.14%)
since 11/15/18
52-Week
1.70 +172.35%
on 05/11/18
4.75 -2.53%
on 02/15/19
+2.53 (+120.48%)
since 02/15/18

Most Recent Stories

More News
Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock

Agios' (AGIO) loss tops estimates in Q4. Its precision medicine Tibsovo receives the FDA nod and leads to significant year-over-year revenue growth.

AGIO : 59.29 (+3.26%)
CELG : 90.69 (+0.01%)
BDSI : 4.63 (+3.12%)
SNSS : 0.53 (unch)
Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates

Acorda (ACOR) rides high on earnings and revenue beat in Q4. The company plans the US launch of Inbrija in first-quarter 2019.

MYL : 31.84 (+1.02%)
BDSI : 4.63 (+3.12%)
ACOR : 14.30 (-8.10%)
SNSS : 0.53 (unch)
Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings

CVS Health (CVS) expects drug price inflation, product launches and higher utilization to fuel growth in Q4.

TGTX : 4.76 (+1.28%)
MGNX : 21.84 (+3.41%)
CVS : 69.53 (+2.72%)
BDSI : 4.63 (+3.12%)
The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna

The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna

CLDX : 5.86 (+13.35%)
CYTK : 7.90 (+3.67%)
AEZS : 3.93 (-2.72%)
BDSI : 4.63 (+3.12%)
ADRO : 4.05 (+10.05%)
5 Tiny Biotech Stocks With Superb Growth Potential

A spurt in deal-making has boosted the sector this year which retains the ability to provide outsized gains.

CLDX : 5.86 (+13.35%)
CYTK : 7.90 (+3.67%)
CELG : 90.69 (+0.01%)
AEZS : 3.93 (-2.72%)
BDSI : 4.63 (+3.12%)
LLY : 122.48 (+1.43%)
LOXO : 234.80 (+0.06%)
ADRO : 4.05 (+10.05%)
BMY : 51.67 (+1.65%)
TAK : 20.46 (+1.74%)
Can M&A Activity Drive Quest Diagnostics (DGX) Q4 Earnings?

Quest Diagnostics' (DGX) increasing partnerships with other health care leaders and strategic acquisitions are promising abundant opportunities for the company's top and bottom-line improvement.

MGNX : 21.84 (+3.41%)
TGTX : 4.76 (+1.28%)
DGX : 87.81 (+2.70%)
BDSI : 4.63 (+3.12%)
Vanda (VNDA) Q4 Earnings: What's in Store for the Stock

On Vanda's (VNDA) fourth-quarter 2018 conference call, investor focus will be on the sales figure of its two marketed drugs, Hetlioz and Fanapt.

BDSI : 4.63 (+3.12%)
NVS : 89.88 (+0.97%)
VNDA : 21.11 (+4.92%)
ADRO : 4.05 (+10.05%)
What's in the Cards for Glaxo (GSK) This Earnings Season?

Glaxo's (GSK) Vaccines segment is likely to witness strong sales in the fourth quarter.

BDSI : 4.63 (+3.12%)
NVS : 89.88 (+0.97%)
SGEN : 71.48 (+4.24%)
GSK : 41.24 (+0.93%)
BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA(R)

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain, today announced that a leading...

BDSI : 4.63 (+3.12%)
BioDelivery Sciences International (BDSI) is a Great Momentum Stock: Should You Buy?

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

BDSI : 4.63 (+3.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade BDSI with:

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

2nd Resistance Point 4.87
1st Resistance Point 4.75
Last Price 4.63
1st Support Level 4.51
2nd Support Level 4.39

See More

52-Week High 4.75
Last Price 4.63
Fibonacci 61.8% 3.58
Fibonacci 50% 3.22
Fibonacci 38.2% 2.87
52-Week Low 1.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar